Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial (Q43200044)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 January 2010
edit
Language Label Description Also known as
English
Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial
scientific article published on 13 January 2010

    Statements

    Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit